Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (91-100 of 311) with videos related to

Pageof 32
Sort By:
Critical Care (London, England)|November 21, 2018
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 yearsJulius J Schmidt, Catherina Lueck, Stefan Ziesing, et al.
The European Respiratory Journal|January 28, 2012
Pregnancy outcomes in pulmonary arterial hypertension in the modern management eraXavier Jaïs, Karen M Olsson, Joan A Barbera, et al.
Plos One|June 17, 2021
Comparison of dual-energy computer tomography and dynamic contrast-enhanced MRI for evaluating lung perfusion defects in chronic thromboembolic pulmonary hypertensionTawfik Moher Alsady, Till F Kaireit, Lea Behrendt, et al.
International Journal of Cardiology|March 21, 2021
Application of the REVEAL risk score calculator 2.0 in the PATENT studyRaymond L Benza, Harrison W Farber, Adaani E Frost, et al.
Respiratory Medicine|March 8, 2022
Application of the REVEAL risk score calculator 2.0 in the CHEST studyRaymond L Benza, Harrison W Farber, Adaani E Frost, et al.
Clinical Nuclear Medicine|April 25, 2018
Quantitation of Perfused Lung Volume Using Hybrid SPECT/CT Allows Refining the Assessment of Lung Perfusion and Estimating Disease Extent in Chronic Thromboembolic Pulmonary HypertensionThorsten Derlin, Catharina Kelting, Katja Hueper, et al.
Frontiers in Medicine|April 12, 2021
High Incidence of Epileptiform Potentials During Continuous EEG Monitoring in Critically Ill COVID-19 PatientsBarbara Schultz, Terence Krauß, Maren Schmidt, et al.
The European Respiratory Journal|September 10, 2024
MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH studyMarc Humbert, Paul M Hassoun, Kelly M Chin, et al.
Frontiers in Psychiatry|February 25, 2022
Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center StudyJan Fuge, Da-Hee Park, Thomas von Lengerke, et al.
Open Forum Infectious Diseases|July 28, 2020
Corrigendum to: Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza EpidemicKlaus Stahl, Benjamin Seeliger, Markus Busch, et al.
Pageof 32

Showing results (91-100 of 311) with videos related to

Sort By:
Pageof 32
Critical Care (London, England)|November 21, 2018
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 yearsJulius J Schmidt, Catherina Lueck, Stefan Ziesing, et al.
The European Respiratory Journal|January 28, 2012
Pregnancy outcomes in pulmonary arterial hypertension in the modern management eraXavier Jaïs, Karen M Olsson, Joan A Barbera, et al.
Plos One|June 17, 2021
Comparison of dual-energy computer tomography and dynamic contrast-enhanced MRI for evaluating lung perfusion defects in chronic thromboembolic pulmonary hypertensionTawfik Moher Alsady, Till F Kaireit, Lea Behrendt, et al.
International Journal of Cardiology|March 21, 2021
Application of the REVEAL risk score calculator 2.0 in the PATENT studyRaymond L Benza, Harrison W Farber, Adaani E Frost, et al.
Respiratory Medicine|March 8, 2022
Application of the REVEAL risk score calculator 2.0 in the CHEST studyRaymond L Benza, Harrison W Farber, Adaani E Frost, et al.
Clinical Nuclear Medicine|April 25, 2018
Quantitation of Perfused Lung Volume Using Hybrid SPECT/CT Allows Refining the Assessment of Lung Perfusion and Estimating Disease Extent in Chronic Thromboembolic Pulmonary HypertensionThorsten Derlin, Catharina Kelting, Katja Hueper, et al.
Frontiers in Medicine|April 12, 2021
High Incidence of Epileptiform Potentials During Continuous EEG Monitoring in Critically Ill COVID-19 PatientsBarbara Schultz, Terence Krauß, Maren Schmidt, et al.
The European Respiratory Journal|September 10, 2024
MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH studyMarc Humbert, Paul M Hassoun, Kelly M Chin, et al.
Frontiers in Psychiatry|February 25, 2022
Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center StudyJan Fuge, Da-Hee Park, Thomas von Lengerke, et al.
Open Forum Infectious Diseases|July 28, 2020
Corrigendum to: Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza EpidemicKlaus Stahl, Benjamin Seeliger, Markus Busch, et al.
Pageof 32